Clinical trials
Phase 2 Tourette Syndrome trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emalex Biosciences Inc. | 2 |
| Holland Bloorview Kids Rehabilitation Hospital | 1 |
| University Health Network, Toronto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tourette Syndrome | 4 |
| 22q11 Deletion Syndrome | 1 |
| Anxiety Disorders | 1 |
| Attention Deficit Disorder with Hyperactivity | 1 |
| Autism Spectrum Disorder | 1 |
| Autistic Disorder | 1 |
| DiGeorge Syndrome | 1 |
| Fragile X Syndrome | 1 |
| Marijuana Abuse | 1 |
| Neurodevelopmental Disorders | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.